A detailed history of Janus Henderson Group PLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Janus Henderson Group PLC holds 4,035,083 shares of LLY stock, worth $3.21 Billion. This represents 1.91% of its overall portfolio holdings.

Number of Shares
4,035,083
Previous 4,141,246 2.56%
Holding current value
$3.21 Billion
Previous $3.75 Billion 4.66%
% of portfolio
1.91%
Previous 2.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$772.14 - $960.02 $82 Million - $102 Million
-106,163 Reduced 2.56%
4,035,083 $3.57 Billion
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $410 Million - $514 Million
565,562 Added 15.82%
4,141,246 $3.75 Billion
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $144 Million - $193 Million
243,729 Added 7.31%
3,575,684 $2.78 Billion
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $481 Million - $567 Million
915,324 Added 37.88%
3,331,955 $1.94 Billion
Q3 2023

Nov 14, 2023

SELL
$434.7 - $599.3 $39.3 Million - $54.2 Million
-90,379 Reduced 3.61%
2,416,631 $1.3 Billion
Q2 2023

Aug 14, 2023

SELL
$350.74 - $468.98 $293 Million - $391 Million
-834,119 Reduced 24.97%
2,507,010 $1.18 Billion
Q1 2023

May 15, 2023

SELL
$310.63 - $364.82 $93 Million - $109 Million
-299,541 Reduced 8.23%
3,341,129 $1.15 Billion
Q4 2022

Feb 14, 2023

SELL
$321.55 - $374.67 $25.7 Million - $29.9 Million
-79,912 Reduced 2.15%
3,640,670 $1.33 Billion
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $62.9 Million - $71.7 Million
-212,073 Reduced 5.39%
3,720,582 $1.2 Billion
Q2 2022

Aug 15, 2022

SELL
$278.73 - $327.27 $320 Million - $376 Million
-1,147,952 Reduced 22.59%
3,932,655 $1.28 Billion
Q1 2022

May 16, 2022

SELL
$234.69 - $291.66 $89.1 Million - $111 Million
-379,771 Reduced 6.96%
5,080,607 $1.45 Billion
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $153 Million - $190 Million
680,641 Added 14.24%
5,460,378 $1.51 Billion
Q3 2021

Nov 16, 2021

SELL
$221.6 - $272.71 $20.4 Million - $25.1 Million
-92,003 Reduced 1.89%
4,779,737 $1.1 Billion
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $25.3 Million - $32.7 Million
-140,005 Reduced 2.79%
4,871,740 $1.12 Billion
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $183 Million - $237 Million
-1,113,176 Reduced 18.17%
5,011,745 $936 Million
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $39.4 Million - $52.2 Million
302,296 Added 5.19%
6,124,921 $1.03 Billion
Q3 2020

Nov 16, 2020

BUY
$146.22 - $169.13 $37.8 Million - $43.7 Million
258,330 Added 4.64%
5,822,625 $862 Million
Q2 2020

Aug 14, 2020

BUY
$136.42 - $164.18 $107 Million - $129 Million
786,253 Added 16.46%
5,564,295 $914 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $57.9 Million - $71.6 Million
-486,130 Reduced 9.23%
4,778,042 $663 Million
Q4 2019

Feb 18, 2020

SELL
$106.92 - $132.43 $99.7 Million - $123 Million
-932,458 Reduced 15.05%
5,264,172 $692 Million
Q3 2019

Nov 14, 2019

SELL
$106.79 - $116.16 $43.9 Million - $47.7 Million
-410,806 Reduced 6.22%
6,196,630 $693 Million
Q2 2019

Jul 31, 2019

SELL
$110.79 - $129.32 $246 Million - $287 Million
-2,217,899 Reduced 25.13%
6,607,436 $732 Million
Q1 2019

Apr 30, 2019

SELL
$111.31 - $131.02 $13.9 Million - $16.3 Million
-124,561 Reduced 1.39%
8,825,335 $1.15 Billion
Q4 2018

Feb 06, 2019

SELL
$105.9 - $118.64 $22.6 Million - $25.3 Million
-213,599 Reduced 2.33%
8,949,896 $1.04 Billion
Q3 2018

Nov 09, 2018

SELL
$85.86 - $107.31 $72.6 Million - $90.7 Million
-845,273 Reduced 8.45%
9,163,495 $983 Million
Q2 2018

Aug 10, 2018

BUY
$75.7 - $86.88 $53 Million - $60.9 Million
700,582 Added 7.53%
10,008,768 $854 Million
Q1 2018

May 14, 2018

SELL
$74.21 - $87.6 $52.6 Million - $62.1 Million
-708,562 Reduced 7.07%
9,308,186 $720 Million
Q4 2017

Feb 09, 2018

SELL
$81.94 - $87.89 $68.9 Million - $73.9 Million
-840,445 Reduced 7.74%
10,016,748 $846 Million
Q3 2017

Nov 14, 2017

BUY
$77.07 - $85.54 $116 Million - $129 Million
1,503,918 Added 16.08%
10,857,193 $0
Q2 2017

Aug 17, 2017

BUY
N/A
9,353,275
9,353,275 $770 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Janus Henderson Group PLC Portfolio

Follow Janus Henderson Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.